These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 17697065

  • 1. A comparison of insulin aspart and regular insulin in elderly patients with type 2 diabetes.
    Meneilly GS.
    Diabetes Obes Metab; 2007 Sep; 9(5):754-5. PubMed ID: 17697065
    [Abstract] [Full Text] [Related]

  • 2. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF, Zhao LB, Li XY, Wang WQ, Sun SY, Chen YH, Hong J, Su TW, Liu JM, Ning G.
    Chin Med J (Engl); 2007 Oct 05; 120(19):1700-3. PubMed ID: 17935674
    [Abstract] [Full Text] [Related]

  • 3. A comparison of mealtime insulin aspart and human insulin in combination with metformin in type 2 diabetes patients.
    Pala L, Mannucci E, Dicembrini I, Rotella CM.
    Diabetes Res Clin Pract; 2007 Oct 05; 78(1):132-5. PubMed ID: 17445933
    [Abstract] [Full Text] [Related]

  • 4. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial.
    Perriello G, Pampanelli S, Porcellati F, Avogaro A, Bosi E, Petrella G, Squatrito S, Furneri S, Marra G, Vitali L, Previti M, Cucinotta D.
    Diabet Med; 2005 May 05; 22(5):606-11. PubMed ID: 15842516
    [Abstract] [Full Text] [Related]

  • 5. The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes.
    Krones R, Schütte C, Heise T.
    Diabetes Obes Metab; 2009 Jan 05; 11(1):41-4. PubMed ID: 19120432
    [Abstract] [Full Text] [Related]

  • 6. The cost effectiveness of rapid-acting insulin aspart compared with human insulin in type 2 diabetes patients: an analysis from the Japanese third-party payer perspective.
    Pollock RF, Valentine WJ, Pilgaard T, Nishimura H.
    J Med Econ; 2011 Jan 05; 14(1):36-46. PubMed ID: 21192769
    [Abstract] [Full Text] [Related]

  • 7. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW.
    Clin Ther; 2007 Jan 05; 29 Suppl D():S135-44. PubMed ID: 18191065
    [Abstract] [Full Text] [Related]

  • 8. A comparison of pharmacokinetics and pharmacodynamics of biphasic insulin aspart 30, 50, 70 and pure insulin aspart: a randomized, quadruple crossover study.
    Thorisdottir RL, Parkner T, Chen JW, Ejskjaer N, Christiansen JS.
    Basic Clin Pharmacol Toxicol; 2009 Mar 05; 104(3):216-21. PubMed ID: 19175369
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes.
    Schmoelzer I, de Campo A, Pressl H, Stelzl H, Dittrich P, Oettl K, Wascher TC.
    Exp Clin Endocrinol Diabetes; 2005 Mar 05; 113(3):176-81. PubMed ID: 15789278
    [Abstract] [Full Text] [Related]

  • 12. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
    Danne T, Råstam J, Odendahl R, Näke A, Schimmel U, Szczepanski R, Moeller J, Deiss D.
    Pediatr Diabetes; 2007 Oct 05; 8(5):278-85. PubMed ID: 17850471
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K, Dornhorst A, Sreenan S.
    Curr Med Res Opin; 2009 Nov 05; 25(11):2601-8. PubMed ID: 19739940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.